LEADERSHIP IN NANOPHARMACEUTICALS Trademark

Trademark Overview


On Thursday, July 15, 2010, a trademark application was filed for LEADERSHIP IN NANOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the LEADERSHIP IN NANOPHARMACEUTICALS trademark a serial number of 85977444. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 14, 2019. This trademark is owned by Cerulean Pharma Inc.. The LEADERSHIP IN NANOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for use in the treatment of oncological diseases or disorders; pharmaceutical preparations for use in the treatment of malignant cancers or neoplasms; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in the treatment of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the treatment of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical

Medical and scientific research services, namely, research, development, analytical, formulation, and product development services in the pharmaceutical field

General Information


Serial Number85977444
Word MarkLEADERSHIP IN NANOPHARMACEUTICALS
Filing DateThursday, July 15, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 14, 2019
Registration Number4243699
Registration DateTuesday, November 13, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2010
Attorney NameDavid Ehrlich
Law Office Location CodeM80
Employee NameEVANKO, PATRICIA MALES
CorrespondentDAVID EHRLICH
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
NEW YORK, NY 10036

Trademark Statements


Disclaimer with Predetermined Text"NANOPHARMACEUTICALS"
Goods and ServicesPharmaceutical preparations for use in the treatment of oncological diseases or disorders; pharmaceutical preparations for use in the treatment of malignant cancers or neoplasms; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in the treatment of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the treatment of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical
Goods and ServicesMedical and scientific research services, namely, research, development, analytical, formulation, and product development services in the pharmaceutical field
Pseudo MarkLEADERSHIP IN NANO PHARMACEUTICALS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 14, 2019
Primary Code005
First Use Anywhere DateMonday, May 21, 2012
First Use In Commerce DateMonday, May 21, 2012

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 14, 2019
Primary Code042
First Use Anywhere DateFriday, December 31, 2010
First Use In Commerce DateFriday, December 31, 2010

Trademark Owner History


Party NameCerulean Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Party NameCerulean Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameCerulean Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, June 14, 2019CANCELLED SEC. 8 (6-YR)
Monday, November 13, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 11, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 11, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 13, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, October 10, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, October 9, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, October 1, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 5, 2012NOTICE OF PSEUDO MARK MAILED
Tuesday, September 4, 2012STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 24, 2012USE AMENDMENT FILED
Tuesday, September 4, 2012DIVISIONAL PROCESSING COMPLETE
Tuesday, July 24, 2012DIVISIONAL REQUEST RECEIVED
Tuesday, July 24, 2012TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, July 24, 2012TEAS STATEMENT OF USE RECEIVED
Wednesday, March 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, March 6, 2012EXTENSION 2 GRANTED
Wednesday, February 8, 2012EXTENSION 2 FILED
Friday, March 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 8, 2012TEAS EXTENSION RECEIVED
Thursday, July 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, July 26, 2011EXTENSION 1 GRANTED
Tuesday, July 26, 2011EXTENSION 1 FILED
Tuesday, July 26, 2011TEAS EXTENSION RECEIVED
Tuesday, February 8, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Wednesday, November 24, 2010NOTICE OF PUBLICATION
Wednesday, November 10, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 10, 2010ASSIGNED TO LIE
Friday, October 29, 2010EXAMINER'S AMENDMENT MAILED
Thursday, October 28, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 28, 2010EXAMINER'S AMENDMENT ENTERED
Thursday, October 28, 2010EXAMINERS AMENDMENT -WRITTEN
Thursday, October 28, 2010ASSIGNED TO EXAMINER
Wednesday, July 21, 2010NOTICE OF PSEUDO MARK MAILED
Tuesday, July 20, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 19, 2010NEW APPLICATION ENTERED IN TRAM